Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SEBUTAPE

K-Number: K840096 · 1984-08-02

ApplicantCuderm Corp.
Decision Date1984-08-02
Product Code
DecisionSubstantially Equivalent

Device Summary

SEBUTAPE is the device name listed in this FDA 510(k) record. The listed applicant is Cuderm Corp.. It received FDA 510(k) clearance on 1984-08-02 under 510(k) number K840096. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SEBUTAPE?

SEBUTAPE is a medical device that received FDA 510(k) clearance on 1984-08-02. The listed applicant is Cuderm Corp.. The 510(k) number is K840096.

When did SEBUTAPE receive FDA 510(k) clearance?

SEBUTAPE received FDA 510(k) clearance on 1984-08-02, under 510(k) number K840096.

Who is the listed applicant for SEBUTAPE?

The FDA 510(k) record lists Cuderm Corp. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑